GLP1R and obesity due to melanocortin 4 receptor deficiency: Originally developed for type 2 diabetes and obesity management, GLP‐1 RAs act through multiple mechanisms including appetite suppression, delayed gastric emptying, and enhanced insulin sensitivity.1, 3